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Abstract
Background: Production of native antigens for serodiagnosis of helminthic infections is laborious and hampered by batch-
to-batch variation. For serodiagnosis of echinococcosis, especially cystic disease, most screening tests rely on crude or
purified Echinococcus granulosus hydatid cyst fluid. To resolve limitations associated with native antigens in serological tests,
the use of standardized and highly pure antigens produced by chemical synthesis offers considerable advantages, provided
appropriate diagnostic sensitivity and specificity is achieved.
Methodology/Principal Findings:Making use of the growing collection of genomic and proteomic data, we applied a set of
bioinformatic selection criteria to a collection of protein sequences including conceptually translated nucleotide sequence
data of two related tapeworms, Echinococcus multilocularis and Echinococcus granulosus. Our approach targeted alpha-
helical coiled-coils and intrinsically unstructured regions of parasite proteins potentially exposed to the host immune
system. From 6 proteins of E. multilocularis and 5 proteins of E. granulosus, 45 peptides between 24 and 30 amino acids in
length were designed. These peptides were chemically synthesized, spotted on microarrays and screened for reactivity with
sera from infected humans. Peptides reacting above the cut-off were validated in enzyme-linked immunosorbent assays
(ELISA). Peptides identified failed to differentiate between E. multilocularis and E. granulosus infection. The peptide
performing best reached 57% sensitivity and 94% specificity. This candidate derived from Echinococcus multilocularis
antigen B8/1 and showed strong reactivity to sera from patients infected either with E. multilocularis or E. granulosus.
Conclusions/Significance: This study provides proof of principle for the discovery of diagnostically relevant peptides by
bioinformatic selection complemented with screening on a high-throughput microarray platform. Our data showed that a
single peptide cannot provide sufficient diagnostic sensitivity whereas pooling several peptide antigens improved
sensitivity; thus combinations of several peptides may lead the way to new diagnostic tests that replace, or at least
complement conventional immunodiagnosis of echinococcosis. Our strategy could prove useful for diagnostic
developments in other pathogens.
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Introduction
For serodiagnosis of human helminthic infections, many
currently used tests rely on native antigens, either extracted from
whole worms (somatic antigens) maintained in laboratory animals,
or cultivated in vitro to obtain excretory/secretory products
(metabolic antigens). These natural antigens are limited in
availability and suffer from batch-to-batch variation. A number
of Echinococcus proteins have been recombinantly produced and
tested for use in serodiagnosis [1–6] but to our knowledge, only
recombinant EmII/3-10 [7,8] and its related sequence Em18 [9]
are successfully applied in commercial test kits. Recombinantly
expressed antigens used in diagnostic tests require a high degree of
purification to avoid cross-reactivity due to contaminants from the
expression system. Unspecific binding and cross-reactivity are
major problems with both, extracts of whole worms [10,11] and
recombinant proteins [12]. For improving diagnostic test perfor-
mance, it is desirable to identify highly specific and highly reactive
epitopes from the proteome of the pathogen in question and
synthetically produce the corresponding peptide antigens. Syn-
thetic peptides are advantageous for diagnostic applications since
they are well defined, easily produced in large amounts, highly
pure and often cost-saving if compared to the production of
natural antigen in animal models or in vitro culture. Applications of
peptides in immunodiagnosis of different parasitic diseases were
given by Noya et al. [13].
The availability of an increasing number of pathogen genomes
is boosting basic research as well as applied science. In the field of
parasitological diagnostics, sequencing of parasites genomes also
creates new opportunities. Annotated genomes and proteomes are
available for some of the medically important protozoan
pathogens, such as Plasmodium species and some Kinetoplastida
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species. Following the genome of the parasitic nematode Brugia
malayi [14], the genome of Schistosoma mansoni, a blood vessel
dwelling trematode, has recently been released [15] as well as a
draft genomic sequence for Schistosoma japonicum [16] and more
genome data from various helminth species are to be expected in
the near future (see for example http://www.sanger.ac.uk/
Projects/Helminths/ or http://www.nematode.net/). Currently,
proteins predicted from ESTs, whole genomes or contigs are
available for data mining already from a considerable number of
helminth species. Using the sequence data available in the public
domain, we have designed and tested a pathway for identifying
novel antigens for serodiagnostic test development.
Our selection procedure for peptide antigens relied on the
application of bioinformatic filters to collections of protein
sequences, including conceptually translated nucleotide sequence
data. The selection criteria aimed at proteins located to the host-
parasite interface. Such proteins are potentially seen by the host
immune system and may elicit an immune response and thus
represent good candidates of diagnostic antigens. Our in silico
analysis therefore prioritized proteins containing a sorting signal
directing the protein to the extracellular space (PSORT II [17]),
transmembrane domains (TMHMM II [18]), or a C-terminal
signature sequence for addition of glycosyl phosphatidylinositol
(GPI) anchor (GPI-som [19]). These prediction algorithms require
full length amino acid sequences with complete N- and C-termini,
thus excluding the use of most EST libraries. The majority of
proteins generally display well defined three dimensional struc-
tures, which is mostly globular. Our selection procedure preferred
sequences in which the chemically synthesized peptide also adopts
a natural conformation in vitro. There are two structural motifs
meeting this claim. Firstly, the intrinsically unstructured regions
(IUR) that lack a well defined three dimensional structure
displaying an extended conformation that can be identified for
example by IUPred [20]. Secondly the alpha-helical coiled-coil
motif predicted for example by Paircoil2 [21]. Alpha-helical
coiled-coils are believed to readily fold into a stable structure in
aqueous solution [22]. A microarray platform served for testing the
diagnostic potential of the peptides selected in silico. Using a high-
throughput microarray format brings together the advantages of
low reagent consumption and rapid multiplexed analysis.
Particularly in diagnostics, the possibility of testing the reactivity
of a given serum sample with multiple antigens simultaneously
harbors great benefits. Promising candidates identified on
microarray were further explored and validated for use in ELISA.
We have carried out the proof-of-principle for bioinformatic
selection of suitable long synthetic peptides (LSPs) for the
tapeworms Echinococcus multilocularis and Echinococcus granulosus, both
of major medical importance causing alveolar (AE) and cystic
echinococcosis (CE), respectively. CE and particularly AE, due to
its infiltrative and/or space-occupying growth, are severe diseases
with high fatality rate and poor prognosis if managed incorrectly
[23]. The importance of alveolar echinococcosis is not represented
by the number of reported cases but rather by the severity of the
disease in the individual patient [24]. Standard diagnostic tests for
human echinococcosis, AE as well as CE, imply imaging
techniques such as ultrasonography, x-ray and computer tomog-
raphy, as well as serological tests based on enzyme-linked
immunosorbent assay (ELISA) and immunoblots [25]. Antigens
used in these serodiagnostic tests were developed from crude
extracts to purified fractions to recombinant antigens and for E.
multilocularis to vesicular fluid originating from in vitro cultivated
metacestodes [26]. Despite substantial improvements have been
achieved, the main screening test still relies on the availability and
quality of native antigens, i.e. hydatid fluid of Echinococcus granulosus
cysts collected from naturally infected intermediate hosts at the
slaughterhouse. One study reported that source and quality or
fertility of cysts are critical for test outcome. This called for
standardization of antigens and test methods [10]. To produce a
robust and reproducible test for the routine diagnostic laboratory,
we have evaluated the performance of chemically synthesized
peptides in comparison to natural (EgHF, EM2) [26,27] and
recombinant antigen (EmII/3-10) [7].
Materials and Methods
Ethics statement
Ethical clearance for retrospective use of anonymized patient
sera for test development and quality control was obtained from
the ethical committee (Ethikkommission beider Basel).
Human serum samples
Sera of healthy blood donors living in Switzerland were used to
define a cut-off for distinguishing between positive and negative test
results. In ELISA, 50 blood donor sera were used. In microarray, a
single serum and 2 pools made of 5 sera each were used. For testing
diagnostic peptide reactivity in ELISA, 44 sera from E. multilocularis-
and 35 sera from E. granulosus-infected patients from Central Europe
were used. All echinococcosis patients had active hepatic lesions of
either CE1 or CE2 type (WHO-IWGE standardized classification)
and all sera were sampled prior to any therapeutic intervention, i.e.
before surgery and/or chemotherapy. Diagnoses were confirmed
serologically as described by Mu¨ller et al. [26], in complementation
to the clinical diagnosis based on imaging procedures and, if
available, retrospective histopathological investigations. For testing
cross-reactivity of the peptides, sera from patients with following
infections were used (concomitant echinococcosis was ruled out by
clinical and serological criteria): 2 trichinellosis, 2 trichuriasis, 10
toxocariasis, 8 ascariasis, 1 anisakiasis, 2 hookworm infection, 8
strongyloidiasis, 10 filariasis (Loa loa, Mansonella perstans, Onchocerca
volvulus), 10 fascioliasis, 1 paragonimiasis, 11 schistosomiasis
(Schistosoma mansoni, S. haematobium, S. mekongi), 12 neurocysticercosis
Author Summary
Crude or purified, somatic or metabolic extracts of native
antigens are routinely used for the serodiagnosis of human
helminthic infections. These antigens are often cross-
reactive, i.e., recognized by sera from patients infected
with heterologous helminth species. To overcome limita-
tions in antigen production, test sensitivity and specificity,
chemically synthesized peptides offer a pure and stan-
dardized alternative, provided they yield acceptable
operative characteristics. Ongoing genome and proteome
work create new resources for the identification of
antigens. Making use of the growing amount of genomic
and proteomic data available in public databases, we
tested a bioinformatic procedure for the selection of
potentially antigenic peptides from a collection of protein
sequences including conceptually translated nucleotide
sequence data of Echinococcus multilocularis and E.
granulosus (Plathyhelminthes, Cestoda). The in silico
selection was combined with high-throughput screening
of peptides on microarray and systematic validation of
reactive candidates in enzyme-linked immunosorbent
assay. Our study proved the applicability of this approach
for selection of peptide antigens with good diagnostic
characteristics. Our results suggested the pooling of
several peptides to reach a high level of sensitivity
required for reliable immunodiagnosis.
Selection of Diagnostic Antigens by Microarray
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(Taenia solium), 1 taeniasis (Taenia saginata), 1 diphyllobothriasis and
26 amoebic liver abscess (Entamoeba histolytica).
Sequence selection and peptide design
Protein sequences of Echinococcus multilocularis and E. granulosus
were retrieved from NCBI Entrez Protein Database on October
16, 2007. NCBI Entrez Protein Database are compiled from a
variety of sources with daily updates, including SwissProt, PIR,
PRF, PDB, and translations from annotated coding regions in
GenBank and RefSeq. To identify putative membrane or
extracellular proteins, the protein sequences were analyzed using
TMHMM II [18] for prediction of transmembrane domains, GPI-
SOM [19] for prediction of glycosylphosphatidylinisotol (GPI)
anchor signals, and PSORT II [17] for prediction of protein
subcellular localization. All protein sequences were further
screened for stretches of alpha-helical coiled-coils using Paircoil2
[21] and intrinsically unstructured regions using IUPred [20].
Both of these structures are believed to adopt native conformation
in aqueous solution and therefore constitute major selection
criteria. Due to the limited number of Echinococcus sequences in
NCBI Entrez Protein Database and few predicted surface proteins
containing stretches of alpha-helical CC and/or IURs, the analysis
was extended to all proteins with alpha-helical coiled-coil and IUR
predictions, irrespective of their predicted locations. This included
known proteins previously tested in immunodiagnosis. To narrow
down protein regions for selection of 30mer peptides, protein
sequences were subjected to prediction of coiled-coil stability
by STABLECOIL (http://biomol.uchsc.edu/cores/biophysics/
stablecoil). In case of IURs antigenicity predictions were performed
using BepiPred [28]. Thus detected regions of high predicted CC
stability or antigenicity were favored. To increase solubility, peptides
were selected to start and end with a hydrophilic or neutral amino acid
and to harbour on average one charged amino acid, either positive or
negative, per five residues. In addition, the guidelines suggested by the
manufacturer were followed (http://www.altabioscience.bham.ac.uk/
pdfs/Intro_to_series_SYNTHETIC_PEPTIDES.pdf). From 11 se-
quences listed in table S1, 45 peptides were selected according to
the criteria mentioned above.
Peptides were produced by Fmoc solid phase synthesis (Alta
Bioscience, University of Birmingham, UK). The length of the
peptides was limited by the EpiScan synthesis procedure (Alta
Bioscience, University of Birmingham, UK) to a maximum of 30
amino acids. Thus the length of the peptides used for spotting onto
microarrays ranged between 24 and 30 amino acids with an
additional aminohexanoid acid (AHX) spacer and a biotin at the
N-terminus. Biotin was required to bind peptides to a streptavidin-
coated solid phase, i.e. microscope glass slide for microarrays (Alta
Bioscience, University of Birmingham, UK) or to 96 well plates for
ELISA. In order to remove electric charges from the free C-
terminus, the synthetic peptides were modified by carboxy-
terminal amidation. Thus, both N-terminal and C-terminal
peptide ends were uncharged, mimicking natural segments of
internal protein sequences.
For defining optimal peptide length, we designed extended
variants of the 8 most reactive candidates from the microarray. The
length of extended peptides ranged between 40 and 47 residues
(table 1). Modifications at the N- and C-terminus were identical to
those of the microarray peptides. The extension of peptides was
chosen to increase alpha-helical coiled-coil stability or to combine
epitopes from two single peptides. To target these improved
peptides to E. multilocularis diagnosis, we chose the E. multilocularis
sequences for designing longer peptides. Sequences derived from
antigen B8/1 (accession number BAC77657) and antigen B8/2
(accession number BAD89809). To our knowledge, these were the
first synthetic peptides from any E. multilocularis antigen B sequence
that were serologically evaluated. Alignments of homologous
antigen B8/1- and antigen B8/2-sequences of the two Echinococcus
species are shown in figures S1 and S2, respectively. Antigen B8/1-
sequences of E. granulosus and E. multilocularis showed 86% identity
and antigen B8/2-sequences 93% identity. Peptide longD8-9
coincided with the region of a previously published E. granulosus
epitope EVKYFFER [29], but differed from another published
synthetic peptide p176 [30]: p176 spans the N-terminal region of
antigen B8/1 (amino acids 17–54), while longD8-9 covered the
central part of the protein (amino acids 33–74). Within the overlap
of 26 amino acids, three amino acids differed.
Microarray
A microarray platform was used for screening in silico selected
peptides for reactivity with patients’ sera. The low-density peptide
microarray (Alta Bioscience, University of Birmingham, UK)
featured two blocks, each containing 45 Echinococcus peptide spots,
a spotting control allowing positioning of grid for analysis
(unrelated, TAMRA-labeled peptide), a control for serological
detection (human IgG) and a blank (spotting solution). All
microarray work was done at room temperature. Microarray
slides were blocked for one hour in assay buffer (16PBS pH 7.4,
0.05% Tween20, 3% milk powder). Individual human sera or
serum pools were diluted 1:50 in assay buffer and incubated for
two hours in a moist chamber. Slides were washed for
365 minutes in assay buffer and incubated for one hour with a
1:100 dilution of Cy5-labeled goat anti-human IgG (H+L)
secondary antibody (Jackson ImmunoResearch Laboratories
product number 109-175-088). Slides were washed for 365 min-
Table 1. Original and extended peptides of the 8 most reactive candidates from microarray.
Protein
Accession
number
Microarray
peptide Length
Accession
number
Extended
peptide Length Peptide sequence
EmII/3 AAA50580 D1 29 AAA50580 longD1 43 EQKLRELRAQMVEKESDLADMKNKASAYESKIAELEMLLQQER
EmII/3 AAA50580 D12 25 AAA50580 longD12 40 DEVQREVEAQKVAMAKKEAEKAQAEAELRRMREKHDAKHK
AgB8/1 AAD38373 D8, D9 29 BAC77657 longD8-9 42 KMLGEMKYFFERDPLGQKLVDLLKELEEVFQMLRKKLRTALK
AgB8/2 AAC47169 D11 27 BAD89809 longD11 45 DPLGQRLVALGNDLTAICQKLQLKIREVLKKYVKNLVEEKDDDSK
EM13 Q07840 A9 29 Q07840 longA9 45 QVQNAKNEPFGTPEQLRKIEDKLRKGIMEEEKTRKAYEEALSSLS
PSCCP* CAD44854 B6 25 CAD44854 longB6 47 ETIQSLCEHNAALQQKLDEANQSVTEVSVQMKVMQQHLHTARVAIQS
EG19 ABI24154 D3 27 ABI24154 longD3 42 EAEAKCLRRPHQRVVKEGEVSKGDEVDGEDRDDECVGGDEGR
*PSCCP: protoscolex-specific coiled-coil protein.
doi:10.1371/journal.pntd.0000771.t001
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utes in assay buffer and quickly rinsed with deionized water before
drying with compressed air. Slides were scanned at 532 and
635 nm using a GenePix 4100A microarray scanner (Bucher
Biotec AG, Basel, Switzerland). Cy5 and TAMRA images and
local background corrected fluorescence intensities (FI) were
acquired using the Axon GenePix Pro 6.0 software. Further
analysis was done in Microsoft Excel. Duplicate FI-values were
averaged. Peptides were determined reactive if FI.1009. This cut-
off was determined by testing single or pooled blood donor
samples (pools made of 5 sera each), calculating average FI
intensities plus 4 times the standard deviation. We chose 4
standard deviations rather than 3 because the majority of duplicate
values differed in more than 20% from each other. This variation
can be explained by unequal spot morphology. Peptides from
reactive spots were forwarded to evaluation of test sensitivity and
specificity performed by ELISA, the current standard format of
routine serodiagnostics.
ELISA
96-well plates (NUNC Immobilizer Streptavidin) were pre-
washed three times using an ELISA plate washer (deionized H2O,
0.05% Tween20) and coated overnight at 4uC with 100 ml/well of
synthetic peptide diluted to 2 mg ml21 in PBS pH 7.4. All
following steps were carried out at room temperature. After
washing, the plates were blocked for one hour with 150 ml/well of
assay buffer (3% milk in PBS pH 7.4, 0.05% Tween20, 0.5 mM
biotin). The plates were washed and incubated for one hour with
human sera diluted 1:200 in assay buffer (100 ml/well). Alkaline-
phosphatase-conjugated goat anti-human IgG antibodies (Sigma
product number A 3187) 1:1000 in assay buffer were used as
secondary antibodies. After washing, 100 ml of conjugate dilution
was added to each well and incubated for one hour, followed by a
final wash. Wells were then incubated for 15 minutes with 100 ml
of p-nitrophenyl phosphate (Sigma product number N 4645) at a
concentration of 1 mg ml21 in substrate buffer (13.2 mM
Na2CO3, 35 mM NaHCO3, 1mM MgCl266H2O, pH 9.6).
Absorbance values (A405nm) were measured at 405 nm in a Tecan
Sunrise microplate absorbance reader. All serum samples were
tested in duplicates. The two values were averaged and blank-
corrected. For distinguishing between positive and negative ELISA
test results, 50 sera from healthy blood donors living in
Switzerland were tested. The cut-off value was determined by
the mean of the blood donor samples plus two standard deviations.
Sensitivity and specificity of the single peptide candidates were
calculated using test results from confirmed echinococcosis
patients as true positives (TP). Blood donors and individuals
infected by other helminths were taken as true negatives (TN). The
working characteristics of the peptide antigens were explored by
receiver-operating characteristics (ROC) plot analysis (Analyse-It,
version 2.21).
To test the impact of pooling peptide candidates, LSP longD12,
longD1 and longD8-9 were mixed in equal parts (mixW) and
applied at the same conditions as described above. The cut-off was
determined by the mean A405nm of fifty blood donor samples plus
2 standard deviations. Sensitivity and cross-reactive behavior was
tested with 30 echinococcosis sera and 15 sera from various
helminth and amoeba infections that had previously shown cross-
reactivity with the single peptides.
Results
Peptide selection
240 entries of E. multilocularis and 940 entries of E. granulosus
proteins were retrieved from NCBI Entrez Protein Database
including redundancies. Combining the outputs of PSORT II,
TMHMM II, GPI-som, IUPred and Paircoil2, led to the selection
of 11 protein candidates (table S1). According to the information
available in GenBank, these proteins were isolated from metaces-
tode or protoscolex tissue, with the possible exception of HSP70, for
which no information on developmental stage was provided.
Six proteins had been reported previously to react with
antibodies from patients’ sera: EmII/3 [7], EM13 [6], P-29 [31],
GRP [32], EG19 [33], AgB8/1 and AgB8/2 [1]. These earlier
findings supported the inclusion of these antigens in our analysis.
In total, 45 peptide sequences from 11 proteins were chosen to be
chemically synthesized and spotted onto microarray. 31 peptides
derived from E. multilocularis and 14 from E. granulosus (table S1).
Screening by peptide microarray
In silico selected peptides were screened for diagnostic potential
on a microarray platform (Alta Bioscience, University of Birming-
ham, UK). From a total of 45 peptides contained in the
microarray, 17 showed reactivity with pooled or single sera from
echinococcosis patients (8/31 peptides from E. multilocularis, 9/14
peptides from E. granulosus). The peptides that reacted above the
cut-off determined from blood donor sera (FI.1009) are listed in
table 2. These 17 peptides were considered to have diagnostic
potential and were therefore subjected to further testing of
specificity and sensitivity. The predicted structure of the reactive
peptide candidates was mostly alpha-helical coiled-coil (7 peptides)
and alpha-helical (7 peptides). 3 peptides were predicted to be
intrinsically unstructured.
Assessing peptide performance in ELISA
The 17 peptides reactive on microarray were carried forward
for evaluating their application in ELISA-based serodiagnosis, the
current routine technique. Test sera from AE and CE patients and
sera from patients with infections other than echinococcosis were
used. Sensitivity, cross-reactivity and impact of peptide length
were evaluated (data not shown). With respect to sensitivity, long
peptides (more than 30 residues) were superior to shorter ones. 3
out of 17 peptides were selected for extensive validation: longD12
(deriving from E. multilocularis EmII/3-10), longD1 (EmII/3-10)
and longD8-9 (E. multilocularis antigen B8/1). All 3 peptides did not
clearly differentiate between AE and CE infections as can be seen
by overlapping standard deviations of A405nm values obtained from
AE and CE sera (figure 1). Peptides longD1 and longD12 derived
from EmII/3-10, a well established antigen specific for the
diagnosis of E. multilocularis infections [8]. In our hands, longD12
reacted with both, AE and CE sera (table 3: AE 10/44; CE 3/35).
This contrasts with previous observations of a specific reactivity of
EmII/3-10 with AE sera. The reactivity of peptide longD1 was
similar to longD12 (AE: 11/44; CE: 2/35). Peptide longD8-9 (E.
multilocularis antigen B8/1) reacted with more CE than AE sera
(AE: 19/44; CE: 26/35) (table 3).
The cut-off values determined from 50 blood donors were
similar for longD8-9 and longD1 with 0.165 and 0.200,
respectively. The cut-off for longD12 was higher with an OD of
0.357. Compared to 90% sensitivity of a commercial E. granulosus
hydatid fluid ELISA used in routine testing [34], the sensitivity of
each single peptide alone was rather low, candidate longD8-9
being the most sensitive with 57%. LongD1 and longD12 both
reached 16%. The specificities of longD8-9, longD1 and longD12
were 94%, 91% and 94% respectively, thus performing in the
range required for a routine diagnostic assay. There were minor
cross-reactivities observed with sera from helminth infections other
than echinococcosis (table 3). Peptide longD8-9 was positive with
1/12 cysticercosis, 1/8 strongyloidiasis and 1/10 schistosomiasis
Selection of Diagnostic Antigens by Microarray
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sera. Peptide longD1 was seropositive with 2/8 strongyloidiasis, 1/
10 toxocariasis, 1/10 filariasis, 1/10 fascioliasis and 3/10
schistosomiasis sera. Peptide longD12 was positive with 1/8
strongyloidiasis, 1/10 toxocariasis, 2/10 schistosomiasis sera.
Cross-reactions with Taenia, Strongyloides and filaria are also seen
in conventional diagnostic assays. We further tested the specificity
with sera from patients suffering from liver abscess due to
Entamoeba histolytica infection. LongD12 was positive with 3/26,
longD1 with 4/26 and longD8-9 with 3/26 amebiasis sera (table 3).
To compare the diagnostic performance of each peptide, a
receiver-operating characteristics (ROC) plot was generated
(figure 2). Candidate longD8-9 emerged as clear favorite, although
on its own not meeting the sensitivity required for antigens applied
in routine diagnostics.
The use of 30–50mer peptides for serology impairs sensitivity
compared to the full length antigen, because peptides likely harbor
less epitopes. We calculated the cumulative sensitivity of the 3
single peptide ELISAs and measured the experimental combina-
tion of the 3 peptides in one antigen mix (mixW). The cut-off of
mixW was 0.352, which is in the same range as the cut-off of one
of its components, namely longD12. By cumulating the individual
results of the 3 assays, the theoretical sensitivity indeed increased
from 57% to 70%, but specificity decreased to 82% (table 4).
Compared to cumulative positivity, pooling the 3 peptides in one
well (mixW) led to a loss of positive test results. In return, the
specificity increased due to a loss of cross-reactions. Positive test
results obtained by single peptide ELISAs compared to pooled
peptide ELISA are summarized in table 5.
Discussion
The use of synthetic peptides as substitutes of native antigen in
immunoassays has been highly recommended for the diagnosis of
infectious diseases by different authors [13,30,35]. Synthetic
peptides are applied successfully in diagnosis of viral and bacterial
infections [36–39]. Compared to a metazoan parasite, viruses and
bacteria in general have smaller genomes and accomplish less
complex post translational protein modifications, which might
imply more rapid success in identification of immunodominant
peptides. It even allows for analysis on whole proteome level [40].
Here, we investigated the use of synthetic peptides of 30–50 amino
acids in length for the use in immunodiagnosis of human hydatid
disease. We provided proof of principle for the selection of
synthetic peptides by bioinformatic means and for screening on a
microarray platform for diagnostic reactivity. 17 out of 45 peptides
on the microarray proofed reactive with sera from echinococcosis
patients.
The peptide performing best in our investigation was longD8-9,
a 42mer peptide deriving from E. multilocularis antigen B8/1. It
reached a sensitivity of 57% and a specificity of 94%. The
reactivity of LSP longD8-9 with sera from AE as well as CE
patients suggests its use for both, patient screening as well as for
follow-up examinations of treated patients. For the latter purpose,
it will be necessary to determine the proportion of patients
seroconverting during treatment. The applicability of our peptide
antigen for monitoring treatment follow-up samples is ongoing
work in our laboratory.
Table 2. Peptides with diagnostic potential identified on microarray.
E.m. E.m. E.m. E.m. E.m. E.m. E.m. E.m. E.g. E.g. E.g. E.g. E.g. E.g. E.g. E.g. E.g.
Protein a) a) a) b) b) b) c) c) d) d) e) e) f) f) f) g) g)
Peptide
name A8 A9 A10 A4 A5 D12 B6 B9 C10 D2 D3 D5 D7 D8 D9 D10 D11
Structure helical helical IUR CC CC CC CC CC helical helical IUR IUR helical helical helical helical CC
Em-pool-1 1 1 0 0 0 1 1 0 0 1 0 1 1 1 0 0 0
Em-pool-2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Em-pool-3 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 0
Em-pool-4* 1 1 1 0 0 1 1 1 0 0 1 0 0 1 0 0 1
Eg-pool-1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 1
Em-3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Em-11 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0
Em-12 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Em-23 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1
Em-24 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
Em-2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Em-15 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 1
Em-18 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0
Em-34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Em-35 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0
*Data incorporates merged results from repeated assays.
a) EM13 (accession Q07840); b) EmII/3 (accession AAA50580); c) Protoscolex specific coiled-coil protein (accession CAD44854); d) HSP70 (accession Q24789); e) EG19
(accession ABI24154); f) Antigen B8/1 (accession AAD38373); g) Antigen B8/2 (accession AAC47169).
1 = positive.
0 = neative.
Em=AE serum.
Eg = CE serum.
doi:10.1371/journal.pntd.0000771.t002
Selection of Diagnostic Antigens by Microarray
www.plosntds.org 5 August 2010 | Volume 4 | Issue 8 | e771
Figure 1. No clear discrimination of A405nm values measured from alveolar echinococcosis (AE) and cystic echinococcosis (CE) sera.
Following peptides served as antigens: 1A) longD8-9, cut-off 0.165. 1B) longD1, cut-off 0.200. 1C) longD12, cut-off 0.357. Bars represent mean and
standard deviation. m Alveolar echinococcosis (AE); % Cystic echinococcosis (CE).
doi:10.1371/journal.pntd.0000771.g001
Table 3. Numbers of sera tested positive with peptides longD12, longD1 and longD8-9.
Peptide longD8-9 longD1 longD12 Cumulative result
Cut-off A405nm 0.165 0.200 0.357
Total tested Positive Positive Positive Positive
Healthy Blood donors 50 4 4 4 11
Cestoda AE 44 19 11 10 28
CE 35 26 2 3 27
Taeniasis 1 0 0 0 0
Cysticercosis 12 1 0 0 1
Diphyllobotriasis 1 0 0 0 0
Nematoda Trichinellosis 2 0 0 0 0
Trichuriasis 2 0 0 0 0
Anisakiasis 1 0 0 0 0
Hookworm 1 0 0 0 0
Strongyloidiasis 8 1 2 1 2
Toxocariasis 10 0 1 1 2
Filariasis 10 0 1 0 1
Ascariasis 8 0 0 0 0
Trematoda Paragonimiasis 1 0 0 0 0
Fascioliasis 10 0 1 0 1
Schistosomiasis 10 1 3 2 5
Protozoa Amoebiasis 26 3 4 3 8
doi:10.1371/journal.pntd.0000771.t003
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Our results confirm previous reports [38,41] that a test based on
a single peptide needs to be complemented by additional peptides
to reach a sensitivity comparable to the antigen extract. To
compensate for limited sensitivity of individual peptides, we
performed ELISAs with combinations of synthetic peptides
applied as mixtures for coating. We compared these results to
the ‘‘cumulative sensitivity’’, a theoretical value obtained by
summing up the positive results from individual peptide ELISAs
for each serum tested. The cumulative result amounted to a
theoretical sensitivity of 70%. We did not detect this high
sensitivity. In contrast, pooling of 3 peptides in one well led to a
loss of positive signals otherwise obtained with individually tested
peptides. 8/29 echinococcosis samples were lost through pooling.
One reason was suggested by an increased cut-off for pooled
peptides. In some sera similar ODs were observed in individual
test and in peptides mixtures, but due to increased cut-off for
pooled peptides, these sera turned negative. The loss of sensitivity
obtained with pooled peptides in mixW could also be due to
partial occupation of streptavidin binding sites with less reactive
antigen. The same reasons may account for increased specificity.
Combination of peptides in one well led to a loss of unwanted
cross-reactivity with 5/11 previously false positive signals disap-
pearing. Thus in our study, pooling peptides increased specificity,
but lowered sensitivity. In future work peptide mixes might be
optimized by combining peptides with equally good diagnostic
sensitivity and specificity. In particular, the sensitivity of mixes is
likely increased by continuous search for new peptides with
improved diagnostic operating characteristics as substitutes for the
least reactive candidates. The behaviour of peptide mixtures
applied as antigens in ELISA needs further investigation.
To select peptides with broad recognition by human echino-
coccosis patients, our bioinformatic selection aimed at exported or
parasite surface exposed antigens. Such proteins are likely to elicit
an immune response. A major drawback was the scarce number of
full-length Echinococcus spp. protein sequences deposited in public
databases. Thus it might be worthwhile for further studies to adapt
the bioinformatic selection criteria to the use of partial EST
sequences. Our data points out the need for screening more
peptide candidates. Further investigations on whole genome level
are likely to provide additional candidates with sufficient sensitivity
and specificity, which can eventually be combined to a synthetic
antigen pool. Single or pooled LSPs are compatible with high
throughput platform technologies such as luminex or biacore
technology that could replace ELISA in the future.
Figure 2. ROC plot illustrating sensitivity and specificity of LSP longD12, longD1, longD8-9. Diagonal line (orange): No discrimination;
Square (green): longD8-9; Triangle (dark blue): longD1; Circle (light blue): longD12.
doi:10.1371/journal.pntd.0000771.g002
Table 4. Sensitivity and specificity of peptides longD12,
longD1 and longD8-9.
Peptide total AE+CE TP FN TN FP Sensitivity Specificity
longD8-9 79 45 34 120 7 57% 94%
longD1 79 13 66 115 12 16% 91%
longD12 79 13 66 127 8 16% 94%
cummulative 79 55 24 104 23 70% 82%
TP= true positive, FN= false negative, TN= true negative, FP = false positive.
doi:10.1371/journal.pntd.0000771.t004
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Additionally to surface or extracellular localization, one
criterion during bioinformatic selection was prediction of second-
ary structures. Alpha-helical coiled-coils and intrinsically unstruc-
tured proteins are believed to adopt native conformation in
aqueous solution and might therefore be well suited for
immunoassays. It is widely accepted that the majority of epitopes
are of the conformational type [42]. Our results showed that for
diagnostic purposes the predicted alpha-helical and alpha-helical
coiled-coil peptides were superior to peptides deriving from
intrinsically unstructured regions. Among the serum-reactive
peptides identified by microarray screening, 14 peptides were of
predicted alpha-helical organization, while only 3 peptides derived
from intrinsically unstructured regions. Furthermore, during our
extensive testing of candidates, all IUR peptides were dismissed
due to lack of sensitivity.
In addition to the secondary and tertiary structure of a peptide,
a further determinant for recognition is the immobilization of
peptides to the solid phase used in an immunodiagnostic test.
Antibody capture by peptides crucially depends on the accessibility
of key residues and therefore the introduction of a spacer molecule
to spatially separate the peptide from its carrier protein is vitally
important [43]. The peptides in our study were synthesized with
an N-terminal AHX-spacer coupled to biotin. The biotin was used
to immobilize the peptide antigen to a streptavidin-coated solid
phase, i.e. microscope glass slides and 96-well ELISA plates.
Coating the biotinylated peptides to non-streptavidin surfaces such
as Immulon 2HB (Thermo Scientific) or Poly Sorp (NUNC)
ELISA plates, led in those samples tested to discrepancies of
duplicate values and mostly reduced A405nm values, in a non-linear
manner (data not shown). Immobilization of peptides by direct
adsorbance to the polystyrene surface might lead to sterical
blockage of key residues necessary for interaction with antibodies
and thus decrease the A405nm values. Similarly, HIV-1 peptides
showed in ELISA increased test sensitivity and specificity when
immobilized via biotin-streptavidin [44]. Surfaces functionalized
with streptavidin guarantee a directional, highly dense and
reproducible coating of biotinylated peptide antigens. It has been
shown that the direction of peptide immobilization is of secondary
importance as long as peptides deriving from internal protein
sequences are investigated [43]. Interactions of internal sequences
do not depend on free N- or C-terminus and therefore attachment
of spacer and carrier molecules can be achieved successfully at
both termini of the peptide.
Our approach represents an alternative to peptide selection by
phage display [45,46]. The bioinformatic selection avoids
construction and handling of phage display libraries and panning
procedures. The most important limitation to successful panning
consists in the lack of selective antibodies. Antibody purification
from human sera requires pure and specific antigen, which
generally is not yet available. Our bioinformatic approach to
peptide selection reduces complex lab work and is compatible with
screening on peptide microarray. In our hands, this platform
proved highly suitable for investigation of antigen-antibody
interaction.
Supporting Information
Figure S1 Alignment of E. granulosus and E. multilocularis
antigenB8/1 sequences with location of peptide D8, D9 and
longD8-9.
Found at: doi:10.1371/journal.pntd.0000771.s001 (0.42 MB TIF)
Figure S2 Alignment of E. granulosus and E. multilocularis
antigenB8/2 sequences with location of D11 and longD11.
Found at: doi:10.1371/journal.pntd.0000771.s002 (0.44 MB TIF)
Table 5. Comparison of positivity achieved by single peptides,
cumulative results of single peptides and peptide pool mixW.
longD8-9 longD1 longD12 cumulative result mixW
Em-1 1 1 0 1 1
Em-5 1 0 0 1 0
Em-9 1 1 0 1 1
Em-14 1 1 0 1 1
Em-27 1 0 0 1 1
Em-31 0 0 1 1 0
Em-38 0 1 0 1 1
Em-39 1 0 1 1 1
Em-40 1 0 0 1 0
Em-41 1 1 0 1 1
Em-42 0 1 0 1 1
Em-44 1 0 0 1 1
Em-45 0 1 1 1 1
Em-47 0 0 1 1 1
Em-53 1 0 0 1 1
Eg-1 1 0 1 1 1
Eg-2 1 0 0 1 0
Eg-3 1 0 0 1 0
Eg-11 1 0 0 1 1
Eg-12 0 0 0 0 0
Eg-13 1 0 0 1 0
Eg-14 1 1 0 1 1
Eg-22 1 0 0 1 1
Eg-24 1 0 0 1 0
Eg-25 1 0 1 1 1
Eg-28 1 0 0 1 1
Eg-29 1 0 0 1 1
Eg-31 1 0 0 1 1
Eg-32 1 0 0 1 1
Eg-34 0 1 0 1 0
N-7 1 1 1 1 1
N-24 0 0 1 1 1
N-25 0 1 0 1 0
N-35 0 0 0 0 0
T-15 0 0 0 0 0
T-16 0 0 1 1 1
T-17 1 1 0 1 0
T-20 0 1 0 1 0
C-10 1 0 0 1 0
C-12 0 0 0 0 0
C-14 0 0 0 0 0
A-4 0 1 1 1 1
A-23 1 0 0 1 0
A-24 1 0 0 1 1
A-26 0 0 1 1 1
1 = positive.
0 = negative.
Em= E. multilocularis infection.
Eg = E. granulosus infection.
N = nematoda infection.
C = cestoda infection.
T = trematoda infection.
A = amoeba infection.
doi:10.1371/journal.pntd.0000771.t005
Selection of Diagnostic Antigens by Microarray
www.plosntds.org 8 August 2010 | Volume 4 | Issue 8 | e771
Table S1 Final set of peptides spotted onto microarray.
Found at: doi:10.1371/journal.pntd.0000771.s003 (0.12 MB
DOC)
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